Universitätsklinikum der Ruhr-Universität Bochum
Welcome,         Profile    Billing    Logout  
 3 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Roghmann, Florian
ARISS, NCT03869385: Albumin Replacement Therapy in Septic Shock

Terminated
3
440
Europe
Albutein® 200 g/L or Plasbumin® 20, Human Albumin 20%
Jena University Hospital, German Research Foundation, Instituto Grifols, S.A., University Hospital Goettingen, SepNet - Critical Care Trials Group, Center for Sepsis Control and Care, Germany
Septic Shock
07/22
06/23
ARASAFE, NCT05676203: A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients

Recruiting
3
250
Europe
Standard ADT (androgen deprivation therapy), Standard Darolutamide, Docetaxel
Jena University Hospital, Bayer
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
07/25
01/27
Kiltz, Uta
PASTOR, NCT04062695 / 2018-004254-22: Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement

Recruiting
2
80
Europe
Tofacitinib 5 MG Oral Tablet [Xeljanz], Xeljanz, Placebo oral tablet
Charite University, Berlin, Germany, Pfizer Pharma GmbH, unrestricted grant
Psoriatic Arthritis, Spondylitis, Sacroilitis
12/23
12/23
ASSIST, NCT05171270: AsseSSing Impact in pSoriatic Treatment

Completed
N/A
503
Europe
Questionnaire
University of Oxford, Amgen
Psoriatic Arthritis
03/22
03/22
Lupus-Best, NCT05714930: LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus

Recruiting
N/A
606
Europe
Treat-to-target as a new treatment concept
Heinrich-Heine University, Duesseldorf, University Hospital Heidelberg, German Diabetes-Center, Leibniz-Institut in Düsseldorf, Lupus Erythematodes-Selbsthilfegemeinschaft e.V.
Systemic Lupus Erythematosus
04/26
09/26

Download Options